Form 4: Adial Pharmaceuticals Director Receives Stock Grant
Insider Transaction (Form 4)
Wendy B. Young, a Director of Adial Pharmaceuticals, Inc., received 25,666 shares of common stock on September 17, 2026.
Summary
- Grant/award: acquired 25,666 Stock Option (Right to Buy) on September 17, 2026; holds 25,666 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Wendy B. Young — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-17 | Grant/award | Stock Option (Right to Buy) | 25,666 | — | — | 25,666 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-17 | Grant/award (25,666 shares) |
Keywords
insider transaction, Form 4, ADIL, ADIAL PHARMACEUTICALS, INC., neutral, Wendy B. Young
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.